Isaac Antonios
Known title: PresidentCIK: 0001487465
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Zacks Initiates Coverage of Live Ventures (LIVE) with Neutral Rating. Zacks Research has begun coverage of Live Ventures Incorporated and assigned a neutral rating. The initiation adds the stock to Zacks' analyst universe, which may increase analyst visibility. The company currently trades with a trailing P/E of 8.0 and is near the lower end of its 52‑week range, while the RSI of 41.7 suggests modest momentum.
Transaction History
| MGRX | ▲ Buy | Grant | 60,000 | $0 | 4/10/2025 | View on chart |
| LIVE | ▼ Sell | Open Market | 9,904 | $256K | 6/30/2023 | View on chart |
| LIVE | ▲ Buy | Option Exercise | 25,000 | $380K | 6/13/2023 | View on chart |
| LIVE | ▼ Sell | Tax Withholding | 15,096 | $380K | 6/13/2023 | View on chart |
| AIFC | ▲ Buy | Grant | 125,787 | $0 | 1/5/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement
Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement. Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.